About Carey-Fineman-Ziter syndrome
Carey-Fineman-Ziter syndrome is a rare disease catalogued by Orphanet (ORPHA:1358). It is associated with the MYMX, MYMK genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Carey-Fineman-Ziter syndrome trials.
Search ClinicalTrials.gov for "Carey-Fineman-Ziter syndrome" or filter by Orphanet code ORPHA:1358 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Carey-Fineman-Ziter syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Carey-Fineman-Ziter syndrome. Updated daily.